SIGNET GRAPHENE TECHNOLOGIES ANNOUNCES PCT FILING FOR GLOBAL PROTECTION
< >
Palm Beach, Florida April 17, 2019. Mr. E.W. Letiziano, CEO, Signet International Holdings, Inc. (otc: SIGN) announced that the company, in association with Florida International University has filed yet another patent to support its January 22, 2019 approved patent. The approved patent trademarked by the company, “deIce 477,” cites over 16 Claims and Drawings.
“This PCT patent will give us protection in a large number of countries,” said Mr. Bradley Nelson, Vice President and Chief Engineer of the company’s subsidiary.
The PCT (Patent Cooperation Treaty) provides international protection implementing a unified legal agreement between all member countries that have ratified the 1970 accord.
The company expects a quick turnaround from the Patent Office, since its examination revealed no prior art as alluded to in the original filing. Mr. Nelson is currently evaluating development and testing procedures with the FIU team of engineers to staff and equip the FIU labs facilities.
Forward Looking Safe Harbor Statement: This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the near future. There are a number of factors that could cause actual results and developments to differ materially from forecasted results. These risks and uncertainties include product demand, market competition, delays in website development, and risks inherent in our operations. For a discussion of these risks and uncertainties, please see our filings with the Securities and Exchange Commission. Our public filings with the SEC are available from commercial document retrieval services and at the website http://www.sec.gov
Uptick Newswire Radio
Uptick_Newswire_white
Interview with Signet CEO, Mr. Ernest Letiziano,
on Uptick Newswire Radio, April 9, 2019
Ernie_portrait_smMr. Letiziano discusses Signet’s latest developments in next generation technologies, including the ConnREAP™ medical device that prevents amputation, the 3D Graphene-based deicing technology, dubbed the “deIce 477™”, and the revolutionary new InCharge™ battery device –a patented, compact, magnetic-based energy source that not only produces energy but charges itself. Click on the below link to listen to the interview in full:
Uptick-Newswire-SIGNET-CEO-Interview-4-9-19b.mp3
berkshireHathawaySignet International Holdings, Inc. (SIGN) Announces: Acquisition of the First Instantly Rechargeable Energy Pack Device to Replace All Batteries
April 03, 2019, 11:52 AM Eastern Daylight Time
PALM BEACH, Fla.–(BUSINESS WIRE)–“We acquired all rights to this invention,” says Ernest W. Letiziano, CEO SIGN. “It provides a compact magnetic-based battery device that offers: a large number of cycles a long storage time and an instant charging time. We call it: ‘InCharge’ This is truly a complete and independent unit… In and of Itself.”
Increased reliance on technology-based solutions has necessitated growth in the area of rechargeable batteries. Battery markets have significantly grown in recent decades, and advancements in computing, portable and wearable-sensor applications, including the recent surge of electric vehicle sales. In 2018, battery sales exceeded $65.1 Billion US dollars. One of the most essential obstacles, which limits modern applications of rechargeable batteries is their slow recharging time.
Inventors, Dr Khizroev and Dr. Guduru, reported that experimental analyses have shown that InCharge energy pack can be tailored to provide fabrication methods that will adjust to industry scale. All sizes and shapes can be modified to accommodate industries’ concerns for mass production.
“The future is bright for Signet and our shareholders,” says Letiziano. “Imagine, not being burdened with the trivial task of patiently waiting while charging a cell phone or even an electric automobile. It’s encouraging to be receiving inquiries from multinationals. We anticipate funding from those men and women who choose to transcend beyond the safe blue-chip way of thinking; insightful investors taking an informative risk and seeing our potential.”
Read the article in full here: Business Wire
“SIGNET WILL SHOCK THE WORLD…”
A NEW BATTERY THAT WILL VIRTUALLY LAST FOREVER
“WE HAVE THE ONLY SOLUTION TO BATTERIES RUNNING OUT OF ENERGY
AND WE DON’T HAVE TO DEPEND ON AN OUTLET TO RECHARGE OUR WEAK BATTERIES.”
(EW Letiziano, CEO)
Ernie_portrait_sm
Mr. Ernest W. Letiziano, CEO of Signet
Palm Beach, FL. March 26, 2019 … “We have to endure many limitations in our lives. Moreover, the frustrations to overcome these limitations continue. Imagine, not to be burdened with the trivial task of charging a cell phone or even an electric automobile. Our invention, which we call the InCharge™, will allow you to junk the charger, and not finding yourself sitting on the terminal floor next to an electrical outlet—in your nice suit. We have the only solution to batteries running out of energy, and we don’t have to depend on an outlet to recharge our weak batteries. InCharge™ allows us independence. The possibilities for such a battery are endless. This is a new type of battery, not an attachment. It is a new-patented devise, totally revolutionary. It produces energy, it recharges virtually instantly, it offers a large number of cycles, a long storage time and it is smaller in size. We will actually replace the slow rechargeable batteries.” These are the words of Ernest W. Letiziano, CEO of Signet International Holdings, Inc. (SEC, OTC:SIGN)
tom_d2
Signet President, Mr. Thomas Donaldson
“This is what ‘revolutionary’ is! An invention is without parallel; it cannot be compared with anything on the market; what is faster than instant?” Signet’s President, Thomas Donaldson, added. “We are extremely pleased and excited to introduce this truly incredible new nano-magnetic technology to the market. It will render practically all previous energy storage devices passé. Any device that requires what we refer to today as a ‘battery’ will never be the same again! Think of it—instant recharge, longer lasting, smaller and lighter, and it can be used by anything that requires a battery as a power source.”
khizroev
Dr. Sakhrat Khizroev, co-inventor of the InCharge™
“The goal of [our] invention is to replace today’s chemical-based batteries, which are slow to recharge, with their new solution for energy storage,” said Dr. Sakhrat Khizroev, co-inventor of the InCharge™. “The next step is to develop a prototype with a company that wants to use the technology for its devices. That could take a few months, or longer.”
“The main idea of the innovation is to use magnetic energy as a source of energy,” Dr. Khizroev said. “If your battery loses magnetic energy, you can re-magnetize them in a fraction of a second.” The energy can be transferred wirelessly. Today’s chemistry-based batteries use an external energy source, like a charger, which transfers its charge to the device through a series of chemical reactions that takes minutes to hours. “Tesla’s an example of a technology that can be improved with our magnetic batteries,” Dr. Khizroev said. “Today’s batteries use an external energy source, like a charger, which transfers its charge to the device through a series of chemical reactions that takes minutes to hours…” With this technology …“we can do much better than that. There are no fundamental limits.” *
(*Edited in part by Emon Reiser- Digital Producer, South Florida Business Journal. July 6, 2018.)
For additional information contact:
Signet International Holdings, Inc. (OTC: SIGN)
Palm Beach, Florida, USA 1-561-832-2000
http://www.signetinternationalholdings.com
Email: eletiziano@aol.com or info@signetinternationalholdings.com
Forward Looking Safe Harbor Statement: This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the near future. There are a number of factors that could cause actual results and developments to differ materially from forecasted results. These risks and uncertainties include product demand, market competition, delays in website development, and risks inherent in our operations. For a discussion of these risks and uncertainties, please see our filings with the Securities and Exchange Commission. Our public filings with the SEC are available from commercial document retrieval services and at the website http://www.sec.gov
SIGNET MEDICAL SOLUTIONS, INC.
(A Subsidiary of Signet International Holdings, Inc. OTC: SIGN)
Signet Appoints M. Thomas Boyer Consultant
For the ConnREAP™, New Medical Device Prevents Amputations
Aurora, CO, February 26, 2019. Tom Donaldson, President of Signet International Holdings, Inc. (OTC:SIGN) announced today the appointment of M. Thomas Boyer, V/P, to assume a consulting role in the development of the new medical device, ConnREAP™. “I am pleased that Tom has accepted our offer to help us not only to characterize this incredible device, but to also represent Signet to medical academia. With more than 25 years as a health care leader, and after years of working with Dr. Conn, Tom is conversant with the ConnREAP™ procedure, including the business case and path to successful commercialization. We want to develop this patent and have it ready for market as soon as possible. We believe that Tom will help us achieve this,” says Mr. Donaldson.
The ConnREAP™ medical device, named for its inventor, Dr. John M. Conn, will be offered worldwide as a 5-piece disposable kit. The device will enable physicians—for the first time—to gain optimal access to the leg arteries and facilitate the best use of catheter and balloon equipment to restore blood flow and prevent amputations. According to independent studies, this device can substantially increase the rate of limb salvage. Tens of thousands of limbs could be saved annually in just the USA alone.
M. Thomas Boyer, V/P
M. Thomas Boyer, V/P
“I am very appreciative for the chance to join Signet’s effort and bring this innovation to market” said Boyer. “The ConnREAP device resolves a long-standing challenge of accessing blocked vessels below the knee. Dr. Conn’s invention gives surgeons a new tool to save limbs that are being amputated today. For patients suffering from Critical Leg Ischemia or other issues, the ConnREAP device can be THE tool that saves their leg.”
Colorado resident Mr. Boyer is a health care entrepreneur, former board member for a major hospital system, and the former board chair of one of the largest health care foundations in the United States.
“Our goal is to commercialize the ConnREAP device as quickly as possible,” says E. W. Letiziano, CEO, “the kits must be made available to all surgeons worldwide. In the past few years, we have experienced an upper trend of amputations over 180,000 in the US; imagine the whole world. This must stop. With the proper funding in place, we will drastically reduce this terrible number and make a difference; I hope those with a conscience will contact us. I had no idea this debilitating disease touches so many.”
For additional information contact:
Signet International Holdings, Inc. (OTC: SIGN)
Palm Beach, Florida, USA 1-561-832-2000
http://www.signetinternationalholdings.com
Email: eletiziano@aol.com or info@signetinternationalholdings.com
SIGNET GRAPHENE TECHNOLOGIES, INC.
(a subsidiary of Signet International Holdings, Inc. (OTC: “SIGN”)
Announces the Appointment of Bradley Nelson, Chief Engineer of Project, “deIce 477 ”
Brad photo
Chief Engineer, Mr. Bradley Nelson
Kings Park, NY, February 12, 2019. Tom Donaldson, President, Signet International Holdings, Inc. (SIGN), announced today the appointment of Bradley Nelson, V/P of subsidiary Graphene Technologies, Inc. to assume liaison role in the development of the new deicing project in connection with Florida International University (FIU).
“Brad has the background and credentials, and is very familiar with the FIU Deicing advancement. He will be consulting with Dr. Agarwal, PhD and Chair at FIU. We want to develop this patent to the fullest and have it ready for commercialization as soon as possible; we are confident that Brad will achieve this,” says Mr. Donaldson.
Mr. Nelson has been conducting his research in his lab at Stony Brook University, New York where he has completed the installation of several advanced visualization systems including the “Reality Deck” 1.5 Giga Pixel Display room. He received his Engineering Degree in Aerospace Technology from the State University of New York. He was one of the original designers of the polygon-scanned large screen laser video projection system that was installed at the SAC military facility. While at Ampex Corporation, Mr. Nelson was part of the design team charged with developing the AVA3 computer graphics system and has extensive experience in computer, optical, and electronic engineering including the design and prototyping of multilayer P.C. boards. Mr. Nelson has been granted several U.S Patents. He also developed stereoscopic displays used by Intel, NVidia, Kia, Hewlett Packard, Sony, and the Jet Propulsion Laboratories. He joined SIGN in March 2007.
“I am pleased Brad accepted our offer to head-up this project; his enthusiasm encourages us even more,” says Mr. Ernest Letiziano, CEO, SIGN. “We worked on several projects in the past 12 years. This time, I have to admit, I have never seen Brad so motivated. After all, we call it “deIce 477” because its 477% more efficient. The airlines and especially the travelers will be happy about that. As our strong relationship with our friends at FIU continues to grow, Brad will keep us focused on this and many more FIU projects to come.”
“I am thrilled to accept this appointment to oversee the development of this exciting cutting edge technology,” says Mr. Nelson. Graphene as described in Wikipedia is the basic structural element for carbon nanotubes and other related allotropes of carbon. The hexagonal structure is the strongest material ever tested and the work in this field has resulted in two Nobel Prizes in Physics, “for groundbreaking experiments regarding the two-dimensional material graphene.”
“The potential for developing applications and products for graphene are limitless, in the near future graphene will be everywhere,” Mr. Nelson continued. “Getting in on the ground floor of this revolution of new technology is a dream come true for me. I have found working with Ernie on various projects over the past 12 years to be a pleasure, his up front and transparent nature regarding business operations make for a supportive work environment maintaining critical open communication.”
SIGN is a public holding company established for the purpose of acquiring unique technology and developing products that make a difference. The company has completed its due diligence and expected to offer its Private Placement Memorandum (PPM) to interested, qualified investors early next month.
For additional information contact:
Signet International Holdings, Inc. (OTC: SIGN)
Palm Beach, Florida, USA 1-561-832-2000
http://www.signetinternationalholdings.com
Email: eletiziano@aol.com or info@signetinternationalholdings.com
SIGNET MEDICAL SOLUTIONS, INC.
(A Subsidiary of Signet International Holdings, Inc. OTC: SIGN)
ANNOUNCES ACQUISITION OF A NEW MEDICAL DEVICE TO PREVENT AMPUTATIONS
Colorado Springs, CO January 23, 2019. Signet’s Board of Directors voted unanimously to purchase all rights and title to a revolutionary medical device from POLR Angioscience, LLC. The device, which will be offered worldwide as a 5-piece disposable kit, will enable physicians—for the first time—to gain optimal access to the leg arteries and facilitate the best use of catheter and balloon equipment to restore blood flow and prevent amputations. According to independent studies, this device will substantially increase the rate of limb salvage. Tens of thousands of limbs could be saved per year in the USA alone.
Signet-Conn-John-CSSA
Inventor, Dr. John M.Conn
“We have trademarked our device ConnREAP,” says Mr. Ernest Letiziano, CEO of Signet. “Its inventor, Dr. John Conn, is a vascular surgeon trained at Emory University. He has utilized the device to successfully, consistently overcome severe challenges in reaching and correcting complex blockages in the leg arteries.”
The pain and disability caused by narrowed leg arteries often ends tragically in amputation, and the technical difficulties conquered by the device allow more surgeons to restore effective blood flow. A huge and growing vulnerable population is at risk for limb loss because of aging, diabetes, and hypertension. They can benefit by this device which simplifies access to correcting the root cause: the bulky yellowish build-up of plaque in arteries.
A multinational independent research clinic spent more than a year investigating and reporting on the device. The results were positive and encouraging, with the recommendation to proceed with development. The device is FDA classified as a trocar, and the procedures for which it is used are covered by Medicare and health insurers.
Mr. Tom Donaldson, President of Signet, expressed his gratitude to Dr. Conn and offered staggering statistics. “Our research shows that here in the USA alone we average over 180,000 amputations per year, and all indications are that we may expect more. We know that the mortality rate is well over 50% after one year, not merely from surgery but from the medical results of impaired function. The emotional anguish suffered by these patients is enormous,” says Donaldson. Dr. Conn, who has devoted many years to preventing amputations, noted, “I am very pleased to see this promising device taken to the next level by the Signet team.”
Signet’s Board is determined to make the ConnREAP™ device available to every surgeon in the world by mid-next year. “This is a debilitating disease,” says Mr. Letiziano. “There is no doubt that our ConnREAP™ device will alter the lives of those who are being tormented with making such a frightful decision as amputation. This device will make a difference. We are close to our final design stage and a successful funding offering. Our goal is to start manufacturing and offering the kit for delivery quickly and have patients dancing again. Our stock offering is published and investors are welcome to join us in a meaningful endeavor.”
For additional information contact:
Signet International Holdings, Inc. (OTC: SIGN)
Palm Beach, Florida, USA 1-561-832-2000
http://www.signetinternationalholdings.com
Email: eletiziano@aol.com or info@signetinternationalholdings.com
Forward Looking Safe Harbor Statement: This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the near future. There are a number of factors that could cause actual results and developments to differ materially from forecasted results. These risks and uncertainties include product demand, market competition, delays in website development, and risks inherent in our operations. For a discussion of these risks and uncertainties, please see our filings with the Securities and Exchange Commission. Our public filings with the SEC are available from commercial document retrieval services and at the website http://www.sec.gov
Signet Graphene Technologies, Inc.
(a Subsidiary of Signet international Holdings, Inc., OTC: SIGN)
Signs Agreement with Florida International University (FIU)
GRAPHENE TECHNOLOGY TO DEICE AIRCRAFT ENTERS $1.30 BILLION DEICING MARKET,
TIME-SAVING, MORE EFFICIENT & LESS TOXIC WASTE [1]
Miami, Florida January 15, 2019 Mr. Tom Donaldson, President, Signet International Holdings, Inc. (OTC: SIGN), the parent company of Signet Graphene Technologies, Inc. (SGT), announced today that the company has executed a contract with Florida International University (FIU) to further the development and commercialization of a new deicing technology enhanced by graphene, the revolutionary carbon-based nanotechnology.
Adhesion of ice to the surfaces of aircraft in inclement weather severely compromises aircraft aerodynamic performance. Time-consuming airport deicing operations are performed for safety, causing extensive flight delays for travelers and a heavy financial burden for the airline industry. Airport Lifestyle magazine notes that the average cost of deicing a passenger aircraft is over $7,000 per coating.
deiceingpic3
Icy conditions can severely compromise aircraft aerodynamic performance.
A team of engineers at Florida International University headed up by Professor Arvind Agarwal, PhD, Chair of Mechanical and Materials Engineering and his team in Plasma Forming Laboratory: Ms Jenniffer Bustillos, Dr. Cheng Zhang and Dr. Benjamin Boesl have developed a graphene foam−polymer composite with superior deicing efficiency and strength. (Patent issue Jan. 22, 2019)
The graphene-foam polymer composite provides lightweight coatings and free-standing components with heating abilities, with exceptional thermal stability. The graphene reinforcement also increases the tensile strength of the polymer coating on the aircraft and reduces the impact of nasty toxic chemical runoff seeping into the ground and water.
The patent application, entitled, “Three Dimensional Graphene Foam Reinforced Composite Coating & Deicing Systems Therefrom,” was a result of research conducted by a grant from the U.S. Army Research Office. Signet Graphene Technologies, Inc., intends to further develop the technology and make it ready for mass production. This invention is expected to have a major impact on the aircraft deicing market, which, according to Opus Materials Technologies, the U.S. spends over $1.30 billion in deicing fluids alone.
“This contract marks the first of an exciting ongoing relationship with FIU,” says Donaldson. “This invention is the solution to a very practical problem in air transportation. Critically low temperature conditions are the reasons delays are imminent, costing the airlines and travelers time and money. Although our focus is on time and safety in the airline industry, we are discovering an abundance of uses for this technology. In fact, we are exploring applied applications in solving icing conditions from icy steps; turbine blades and their mechanics, helicopter rotor blades; even private home uses and other subzero problems.”
“It is a pleasure to be associated with FIU,” says Ernest Letiziano, CEO, SIGN. “We were looking for applied use of graphene that can be made available to the public quickly; this invention is the answer to efficiency and toxic waste. The Army Grant technology has been achieved; we will take it from here.”
< >
Palm Beach, Florida April 17, 2019. Mr. E.W. Letiziano, CEO, Signet International Holdings, Inc. (otc: SIGN) announced that the company, in association with Florida International University has filed yet another patent to support its January 22, 2019 approved patent. The approved patent trademarked by the company, “deIce 477,” cites over 16 Claims and Drawings.
“This PCT patent will give us protection in a large number of countries,” said Mr. Bradley Nelson, Vice President and Chief Engineer of the company’s subsidiary.
The PCT (Patent Cooperation Treaty) provides international protection implementing a unified legal agreement between all member countries that have ratified the 1970 accord.
The company expects a quick turnaround from the Patent Office, since its examination revealed no prior art as alluded to in the original filing. Mr. Nelson is currently evaluating development and testing procedures with the FIU team of engineers to staff and equip the FIU labs facilities.
Forward Looking Safe Harbor Statement: This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the near future. There are a number of factors that could cause actual results and developments to differ materially from forecasted results. These risks and uncertainties include product demand, market competition, delays in website development, and risks inherent in our operations. For a discussion of these risks and uncertainties, please see our filings with the Securities and Exchange Commission. Our public filings with the SEC are available from commercial document retrieval services and at the website http://www.sec.gov
Uptick Newswire Radio
Uptick_Newswire_white
Interview with Signet CEO, Mr. Ernest Letiziano,
on Uptick Newswire Radio, April 9, 2019
Ernie_portrait_smMr. Letiziano discusses Signet’s latest developments in next generation technologies, including the ConnREAP™ medical device that prevents amputation, the 3D Graphene-based deicing technology, dubbed the “deIce 477™”, and the revolutionary new InCharge™ battery device –a patented, compact, magnetic-based energy source that not only produces energy but charges itself. Click on the below link to listen to the interview in full:
Uptick-Newswire-SIGNET-CEO-Interview-4-9-19b.mp3
berkshireHathawaySignet International Holdings, Inc. (SIGN) Announces: Acquisition of the First Instantly Rechargeable Energy Pack Device to Replace All Batteries
April 03, 2019, 11:52 AM Eastern Daylight Time
PALM BEACH, Fla.–(BUSINESS WIRE)–“We acquired all rights to this invention,” says Ernest W. Letiziano, CEO SIGN. “It provides a compact magnetic-based battery device that offers: a large number of cycles a long storage time and an instant charging time. We call it: ‘InCharge’ This is truly a complete and independent unit… In and of Itself.”
Increased reliance on technology-based solutions has necessitated growth in the area of rechargeable batteries. Battery markets have significantly grown in recent decades, and advancements in computing, portable and wearable-sensor applications, including the recent surge of electric vehicle sales. In 2018, battery sales exceeded $65.1 Billion US dollars. One of the most essential obstacles, which limits modern applications of rechargeable batteries is their slow recharging time.
Inventors, Dr Khizroev and Dr. Guduru, reported that experimental analyses have shown that InCharge energy pack can be tailored to provide fabrication methods that will adjust to industry scale. All sizes and shapes can be modified to accommodate industries’ concerns for mass production.
“The future is bright for Signet and our shareholders,” says Letiziano. “Imagine, not being burdened with the trivial task of patiently waiting while charging a cell phone or even an electric automobile. It’s encouraging to be receiving inquiries from multinationals. We anticipate funding from those men and women who choose to transcend beyond the safe blue-chip way of thinking; insightful investors taking an informative risk and seeing our potential.”
Read the article in full here: Business Wire
“SIGNET WILL SHOCK THE WORLD…”
A NEW BATTERY THAT WILL VIRTUALLY LAST FOREVER
“WE HAVE THE ONLY SOLUTION TO BATTERIES RUNNING OUT OF ENERGY
AND WE DON’T HAVE TO DEPEND ON AN OUTLET TO RECHARGE OUR WEAK BATTERIES.”
(EW Letiziano, CEO)
Ernie_portrait_sm
Mr. Ernest W. Letiziano, CEO of Signet
Palm Beach, FL. March 26, 2019 … “We have to endure many limitations in our lives. Moreover, the frustrations to overcome these limitations continue. Imagine, not to be burdened with the trivial task of charging a cell phone or even an electric automobile. Our invention, which we call the InCharge™, will allow you to junk the charger, and not finding yourself sitting on the terminal floor next to an electrical outlet—in your nice suit. We have the only solution to batteries running out of energy, and we don’t have to depend on an outlet to recharge our weak batteries. InCharge™ allows us independence. The possibilities for such a battery are endless. This is a new type of battery, not an attachment. It is a new-patented devise, totally revolutionary. It produces energy, it recharges virtually instantly, it offers a large number of cycles, a long storage time and it is smaller in size. We will actually replace the slow rechargeable batteries.” These are the words of Ernest W. Letiziano, CEO of Signet International Holdings, Inc. (SEC, OTC:SIGN)
tom_d2
Signet President, Mr. Thomas Donaldson
“This is what ‘revolutionary’ is! An invention is without parallel; it cannot be compared with anything on the market; what is faster than instant?” Signet’s President, Thomas Donaldson, added. “We are extremely pleased and excited to introduce this truly incredible new nano-magnetic technology to the market. It will render practically all previous energy storage devices passé. Any device that requires what we refer to today as a ‘battery’ will never be the same again! Think of it—instant recharge, longer lasting, smaller and lighter, and it can be used by anything that requires a battery as a power source.”
khizroev
Dr. Sakhrat Khizroev, co-inventor of the InCharge™
“The goal of [our] invention is to replace today’s chemical-based batteries, which are slow to recharge, with their new solution for energy storage,” said Dr. Sakhrat Khizroev, co-inventor of the InCharge™. “The next step is to develop a prototype with a company that wants to use the technology for its devices. That could take a few months, or longer.”
“The main idea of the innovation is to use magnetic energy as a source of energy,” Dr. Khizroev said. “If your battery loses magnetic energy, you can re-magnetize them in a fraction of a second.” The energy can be transferred wirelessly. Today’s chemistry-based batteries use an external energy source, like a charger, which transfers its charge to the device through a series of chemical reactions that takes minutes to hours. “Tesla’s an example of a technology that can be improved with our magnetic batteries,” Dr. Khizroev said. “Today’s batteries use an external energy source, like a charger, which transfers its charge to the device through a series of chemical reactions that takes minutes to hours…” With this technology …“we can do much better than that. There are no fundamental limits.” *
(*Edited in part by Emon Reiser- Digital Producer, South Florida Business Journal. July 6, 2018.)
For additional information contact:
Signet International Holdings, Inc. (OTC: SIGN)
Palm Beach, Florida, USA 1-561-832-2000
http://www.signetinternationalholdings.com
Email: eletiziano@aol.com or info@signetinternationalholdings.com
Forward Looking Safe Harbor Statement: This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the near future. There are a number of factors that could cause actual results and developments to differ materially from forecasted results. These risks and uncertainties include product demand, market competition, delays in website development, and risks inherent in our operations. For a discussion of these risks and uncertainties, please see our filings with the Securities and Exchange Commission. Our public filings with the SEC are available from commercial document retrieval services and at the website http://www.sec.gov
SIGNET MEDICAL SOLUTIONS, INC.
(A Subsidiary of Signet International Holdings, Inc. OTC: SIGN)
Signet Appoints M. Thomas Boyer Consultant
For the ConnREAP™, New Medical Device Prevents Amputations
Aurora, CO, February 26, 2019. Tom Donaldson, President of Signet International Holdings, Inc. (OTC:SIGN) announced today the appointment of M. Thomas Boyer, V/P, to assume a consulting role in the development of the new medical device, ConnREAP™. “I am pleased that Tom has accepted our offer to help us not only to characterize this incredible device, but to also represent Signet to medical academia. With more than 25 years as a health care leader, and after years of working with Dr. Conn, Tom is conversant with the ConnREAP™ procedure, including the business case and path to successful commercialization. We want to develop this patent and have it ready for market as soon as possible. We believe that Tom will help us achieve this,” says Mr. Donaldson.
The ConnREAP™ medical device, named for its inventor, Dr. John M. Conn, will be offered worldwide as a 5-piece disposable kit. The device will enable physicians—for the first time—to gain optimal access to the leg arteries and facilitate the best use of catheter and balloon equipment to restore blood flow and prevent amputations. According to independent studies, this device can substantially increase the rate of limb salvage. Tens of thousands of limbs could be saved annually in just the USA alone.
M. Thomas Boyer, V/P
M. Thomas Boyer, V/P
“I am very appreciative for the chance to join Signet’s effort and bring this innovation to market” said Boyer. “The ConnREAP device resolves a long-standing challenge of accessing blocked vessels below the knee. Dr. Conn’s invention gives surgeons a new tool to save limbs that are being amputated today. For patients suffering from Critical Leg Ischemia or other issues, the ConnREAP device can be THE tool that saves their leg.”
Colorado resident Mr. Boyer is a health care entrepreneur, former board member for a major hospital system, and the former board chair of one of the largest health care foundations in the United States.
“Our goal is to commercialize the ConnREAP device as quickly as possible,” says E. W. Letiziano, CEO, “the kits must be made available to all surgeons worldwide. In the past few years, we have experienced an upper trend of amputations over 180,000 in the US; imagine the whole world. This must stop. With the proper funding in place, we will drastically reduce this terrible number and make a difference; I hope those with a conscience will contact us. I had no idea this debilitating disease touches so many.”
For additional information contact:
Signet International Holdings, Inc. (OTC: SIGN)
Palm Beach, Florida, USA 1-561-832-2000
http://www.signetinternationalholdings.com
Email: eletiziano@aol.com or info@signetinternationalholdings.com
SIGNET GRAPHENE TECHNOLOGIES, INC.
(a subsidiary of Signet International Holdings, Inc. (OTC: “SIGN”)
Announces the Appointment of Bradley Nelson, Chief Engineer of Project, “deIce 477 ”
Brad photo
Chief Engineer, Mr. Bradley Nelson
Kings Park, NY, February 12, 2019. Tom Donaldson, President, Signet International Holdings, Inc. (SIGN), announced today the appointment of Bradley Nelson, V/P of subsidiary Graphene Technologies, Inc. to assume liaison role in the development of the new deicing project in connection with Florida International University (FIU).
“Brad has the background and credentials, and is very familiar with the FIU Deicing advancement. He will be consulting with Dr. Agarwal, PhD and Chair at FIU. We want to develop this patent to the fullest and have it ready for commercialization as soon as possible; we are confident that Brad will achieve this,” says Mr. Donaldson.
Mr. Nelson has been conducting his research in his lab at Stony Brook University, New York where he has completed the installation of several advanced visualization systems including the “Reality Deck” 1.5 Giga Pixel Display room. He received his Engineering Degree in Aerospace Technology from the State University of New York. He was one of the original designers of the polygon-scanned large screen laser video projection system that was installed at the SAC military facility. While at Ampex Corporation, Mr. Nelson was part of the design team charged with developing the AVA3 computer graphics system and has extensive experience in computer, optical, and electronic engineering including the design and prototyping of multilayer P.C. boards. Mr. Nelson has been granted several U.S Patents. He also developed stereoscopic displays used by Intel, NVidia, Kia, Hewlett Packard, Sony, and the Jet Propulsion Laboratories. He joined SIGN in March 2007.
“I am pleased Brad accepted our offer to head-up this project; his enthusiasm encourages us even more,” says Mr. Ernest Letiziano, CEO, SIGN. “We worked on several projects in the past 12 years. This time, I have to admit, I have never seen Brad so motivated. After all, we call it “deIce 477” because its 477% more efficient. The airlines and especially the travelers will be happy about that. As our strong relationship with our friends at FIU continues to grow, Brad will keep us focused on this and many more FIU projects to come.”
“I am thrilled to accept this appointment to oversee the development of this exciting cutting edge technology,” says Mr. Nelson. Graphene as described in Wikipedia is the basic structural element for carbon nanotubes and other related allotropes of carbon. The hexagonal structure is the strongest material ever tested and the work in this field has resulted in two Nobel Prizes in Physics, “for groundbreaking experiments regarding the two-dimensional material graphene.”
“The potential for developing applications and products for graphene are limitless, in the near future graphene will be everywhere,” Mr. Nelson continued. “Getting in on the ground floor of this revolution of new technology is a dream come true for me. I have found working with Ernie on various projects over the past 12 years to be a pleasure, his up front and transparent nature regarding business operations make for a supportive work environment maintaining critical open communication.”
SIGN is a public holding company established for the purpose of acquiring unique technology and developing products that make a difference. The company has completed its due diligence and expected to offer its Private Placement Memorandum (PPM) to interested, qualified investors early next month.
For additional information contact:
Signet International Holdings, Inc. (OTC: SIGN)
Palm Beach, Florida, USA 1-561-832-2000
http://www.signetinternationalholdings.com
Email: eletiziano@aol.com or info@signetinternationalholdings.com
SIGNET MEDICAL SOLUTIONS, INC.
(A Subsidiary of Signet International Holdings, Inc. OTC: SIGN)
ANNOUNCES ACQUISITION OF A NEW MEDICAL DEVICE TO PREVENT AMPUTATIONS
Colorado Springs, CO January 23, 2019. Signet’s Board of Directors voted unanimously to purchase all rights and title to a revolutionary medical device from POLR Angioscience, LLC. The device, which will be offered worldwide as a 5-piece disposable kit, will enable physicians—for the first time—to gain optimal access to the leg arteries and facilitate the best use of catheter and balloon equipment to restore blood flow and prevent amputations. According to independent studies, this device will substantially increase the rate of limb salvage. Tens of thousands of limbs could be saved per year in the USA alone.
Signet-Conn-John-CSSA
Inventor, Dr. John M.Conn
“We have trademarked our device ConnREAP,” says Mr. Ernest Letiziano, CEO of Signet. “Its inventor, Dr. John Conn, is a vascular surgeon trained at Emory University. He has utilized the device to successfully, consistently overcome severe challenges in reaching and correcting complex blockages in the leg arteries.”
The pain and disability caused by narrowed leg arteries often ends tragically in amputation, and the technical difficulties conquered by the device allow more surgeons to restore effective blood flow. A huge and growing vulnerable population is at risk for limb loss because of aging, diabetes, and hypertension. They can benefit by this device which simplifies access to correcting the root cause: the bulky yellowish build-up of plaque in arteries.
A multinational independent research clinic spent more than a year investigating and reporting on the device. The results were positive and encouraging, with the recommendation to proceed with development. The device is FDA classified as a trocar, and the procedures for which it is used are covered by Medicare and health insurers.
Mr. Tom Donaldson, President of Signet, expressed his gratitude to Dr. Conn and offered staggering statistics. “Our research shows that here in the USA alone we average over 180,000 amputations per year, and all indications are that we may expect more. We know that the mortality rate is well over 50% after one year, not merely from surgery but from the medical results of impaired function. The emotional anguish suffered by these patients is enormous,” says Donaldson. Dr. Conn, who has devoted many years to preventing amputations, noted, “I am very pleased to see this promising device taken to the next level by the Signet team.”
Signet’s Board is determined to make the ConnREAP™ device available to every surgeon in the world by mid-next year. “This is a debilitating disease,” says Mr. Letiziano. “There is no doubt that our ConnREAP™ device will alter the lives of those who are being tormented with making such a frightful decision as amputation. This device will make a difference. We are close to our final design stage and a successful funding offering. Our goal is to start manufacturing and offering the kit for delivery quickly and have patients dancing again. Our stock offering is published and investors are welcome to join us in a meaningful endeavor.”
For additional information contact:
Signet International Holdings, Inc. (OTC: SIGN)
Palm Beach, Florida, USA 1-561-832-2000
http://www.signetinternationalholdings.com
Email: eletiziano@aol.com or info@signetinternationalholdings.com
Forward Looking Safe Harbor Statement: This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the near future. There are a number of factors that could cause actual results and developments to differ materially from forecasted results. These risks and uncertainties include product demand, market competition, delays in website development, and risks inherent in our operations. For a discussion of these risks and uncertainties, please see our filings with the Securities and Exchange Commission. Our public filings with the SEC are available from commercial document retrieval services and at the website http://www.sec.gov
Signet Graphene Technologies, Inc.
(a Subsidiary of Signet international Holdings, Inc., OTC: SIGN)
Signs Agreement with Florida International University (FIU)
GRAPHENE TECHNOLOGY TO DEICE AIRCRAFT ENTERS $1.30 BILLION DEICING MARKET,
TIME-SAVING, MORE EFFICIENT & LESS TOXIC WASTE [1]
Miami, Florida January 15, 2019 Mr. Tom Donaldson, President, Signet International Holdings, Inc. (OTC: SIGN), the parent company of Signet Graphene Technologies, Inc. (SGT), announced today that the company has executed a contract with Florida International University (FIU) to further the development and commercialization of a new deicing technology enhanced by graphene, the revolutionary carbon-based nanotechnology.
Adhesion of ice to the surfaces of aircraft in inclement weather severely compromises aircraft aerodynamic performance. Time-consuming airport deicing operations are performed for safety, causing extensive flight delays for travelers and a heavy financial burden for the airline industry. Airport Lifestyle magazine notes that the average cost of deicing a passenger aircraft is over $7,000 per coating.
deiceingpic3
Icy conditions can severely compromise aircraft aerodynamic performance.
A team of engineers at Florida International University headed up by Professor Arvind Agarwal, PhD, Chair of Mechanical and Materials Engineering and his team in Plasma Forming Laboratory: Ms Jenniffer Bustillos, Dr. Cheng Zhang and Dr. Benjamin Boesl have developed a graphene foam−polymer composite with superior deicing efficiency and strength. (Patent issue Jan. 22, 2019)
The graphene-foam polymer composite provides lightweight coatings and free-standing components with heating abilities, with exceptional thermal stability. The graphene reinforcement also increases the tensile strength of the polymer coating on the aircraft and reduces the impact of nasty toxic chemical runoff seeping into the ground and water.
The patent application, entitled, “Three Dimensional Graphene Foam Reinforced Composite Coating & Deicing Systems Therefrom,” was a result of research conducted by a grant from the U.S. Army Research Office. Signet Graphene Technologies, Inc., intends to further develop the technology and make it ready for mass production. This invention is expected to have a major impact on the aircraft deicing market, which, according to Opus Materials Technologies, the U.S. spends over $1.30 billion in deicing fluids alone.
“This contract marks the first of an exciting ongoing relationship with FIU,” says Donaldson. “This invention is the solution to a very practical problem in air transportation. Critically low temperature conditions are the reasons delays are imminent, costing the airlines and travelers time and money. Although our focus is on time and safety in the airline industry, we are discovering an abundance of uses for this technology. In fact, we are exploring applied applications in solving icing conditions from icy steps; turbine blades and their mechanics, helicopter rotor blades; even private home uses and other subzero problems.”
“It is a pleasure to be associated with FIU,” says Ernest Letiziano, CEO, SIGN. “We were looking for applied use of graphene that can be made available to the public quickly; this invention is the answer to efficiency and toxic waste. The Army Grant technology has been achieved; we will take it from here.”
